Sunil Agarwal

Sunil Agarwal is a seasoned professional in the biotechnology and pharmaceutical sectors, currently serving on the Board of Directors for Astria Therapeutics, Inc. and Arvinas, while also holding the position of Venture Partner at Forge Life Science Partners. Previously, Sunil Agarwal contributed as a board member for HI-Bio, Calithera Biosciences, and MyoKardia, and played a pivotal role as President of Research and Development at Juno Therapeutics. Sunil Agarwal's executive experience includes serving as Executive Vice President and Chief Medical Officer at Sana Biotechnology and Ultragenyx Pharmaceutical. Sunil Agarwal received an MD from Tufts University School of Medicine and a BS from Cornell University.